Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medicus Sciences Acquisition (NAS:MSACW) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Medicus Sciences Acquisition Cash Conversion Cycle Related Terms
Medicus Sciences Acquisition Cash Conversion Cycle Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicus Sciences Acquisition Cash Conversion Cycle Chart
MSACW vs GENQ, DUET, AIB: Cash Conversion Cycle Comparison
For the Shell Companies subindustry, Medicus Sciences Acquisition's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicus Sciences Acquisition Cash Conversion Cycle vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Medicus Sciences Acquisition's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Medicus Sciences Acquisition's Cash Conversion Cycle falls into.
Medicus Sciences Acquisition Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Medicus Sciences Acquisition's Cash Conversion Cycle for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicus Sciences Acquisition (MSACW) has a Cash Conversion Cycle of 0.00 as of Sep. 2022. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Medicus Sciences Acquisition and its competitors.
Is Medicus Sciences Acquisition's Cash Conversion Cycle too high?
Medicus Sciences Acquisition's current Cash Conversion Cycle is 0.00. Overall, Medicus Sciences Acquisition has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Medicus Sciences Acquisition's Cash Conversion Cycle compare to GENQ and DUET?
Medicus Sciences Acquisition's Cash Conversion Cycle of 0.00 can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Diversified Financial Services company?
A good Cash Conversion Cycle depends on the Diversified Financial Services industry context. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Medicus Sciences Acquisition and its competitors. Medicus Sciences Acquisition's current Cash Conversion Cycle is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicus Sciences Acquisition stock overvalued right now?
Medicus Sciences Acquisition (MSACW) has a current Cash Conversion Cycle of 0.00. The current Cash Conversion Cycle is 0.00. Medicus Sciences Acquisition's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Medicus Sciences Acquisition (MSACW), the current Cash Conversion Cycle is 0.00 as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MSACW has been successfully added to your 
